StonvexLoading…
StonvexStonvexStonvexCore line items from GDYN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $411.83M | $350.57M | $312.91M | $310.48M |
Operating Income | $-1.90M | $-2.10M | $-5.58M | $-21.01M |
Net Income | $9.67M | $4.04M | $-1.76M | $-29.21M |
EPS (Diluted) | $0.11 | $0.05 | $-0.02 | $-0.42 |
Total Assets | $612.89M | $592.19M | $435.17M | $411.15M |
Total Liabilities | $70.82M | $74.36M | $52.26M | $48.10M |
Cash & Equivalents | $342.06M | $334.65M | $257.23M | $256.73M |
Free Cash Flow OCF − CapEx | $25.27M | $18.43M | $33.22M | $25.58M |
Shares Outstanding | 84.84M | 83.61M | 75.89M | 74.16M |